Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:317-324
Published online before print December 7, 2006, doi: 10.1161/01.ATV.0000254684.80662.44
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/2/317    most recent
01.ATV.0000254684.80662.44v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dumont, O.
Right arrow Articles by Henrion, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dumont, O.
Right arrow Articles by Henrion, D.
Related Collections
Right arrow Remodeling
Right arrow Cell signalling/signal transduction
Right arrow Hypertrophy
Right arrow Peripheral vascular disease
Right arrow Endothelium/vascular type/nitric oxide
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:317.)
© 2007 American Heart Association, Inc.


Vascular Biology

Key Role of the NO-Pathway and Matrix Metalloprotease-9 in High Blood Flow-Induced Remodeling of Rat Resistance Arteries

Odile Dumont; Laurent Loufrani; Daniel Henrion

From the CNRS UMR 6214; INSERM UMR 771; University of Angers, France.

Correspondence to Dr Daniel Henrion, PharmD, PhD, UMR CNRS 6214 - INSERM 771, Faculté de Médecine, Université d’Angers, 49045 Angers, France. E-mail daniel.henrion{at}univ-angers.fr

Objective— Blood flow is altered in metabolic and ischemic diseases with dramatic consequences. Resistance arteries structure and function remodel in response to chronic blood flow changes through a mechanism remaining mainly unknown. We hypothesized that the NO pathway and matrix metalloproteases (MMPs) activation might play a role in flow (shear stress)-induced microvascular remodeling.

Methods and Results— Mesenteric resistance arteries were ligated to alter blood flow in vivo for 4 or 14 days: arteries were submitted to high (HF), low (LF), or normal flow (NF). Rats were treated with L-NAME, the angiotensin converting enzyme inhibitor perindopril or the MMPs inhibitor doxycycline. After 14 days, outward hypertrophic remodeling occurred in HF arteries in association with eNOS overexpression. MMP9 activity increased in the early phase (day 4). HF-remodeling was prevented by L-NAME, eNOS gene knockout, and doxycycline. L-NAME prevented eNOS overexpression and MMPs activation whereas doxycycline only prevented MMPs activation. In LF arteries diameter reduction was associated with a decreased eNOS expression without change in MMPs expression and activation. LF-remodeling was reduced by perindopril.

Conclusions— In resistance arteries, high flow induced diameter enlargement and wall hypertrophy associated with the sequential activation of eNOS and MMP9.

Blood flow is altered in metabolic and ischemic diseases with dramatic consequences. A chronic increase in blood flow (shear stress) in mesenteric resistance arteries induced outward hypertrophic remodeling attributable to the sequential activation of eNOS and MMP9. Lowering blood flow induced a diameter reduction reflecting the loss of flow-dependent dilation.


Key Words: microcirculation (resistance arteries) • remodeling • blood flow • shear stress • endothelium • nitric oxide • matrix metalloproteases




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
E. N.T.P. Bakker, H. L. Matlung, P. Bonta, C. J. de Vries, N. van Rooijen, and E. VanBavel
Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone
Cardiovasc Res, May 1, 2008; 78(2): 341 - 348.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. Dumont, F. Pinaud, A.-L. Guihot, C. Baufreton, L. Loufrani, and D. Henrion
Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improvement by a treatment with hydralazine
Cardiovasc Res, February 1, 2008; 77(3): 600 - 608.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Yan, A. Huang, G. Kaley, and D. Sun
Chronic high blood flow potentiates shear stress-induced release of NO in arteries of aged rats
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3105 - H3110.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Bouvet, E. B. de Chantemele, A.-L. Guihot, E. Vessieres, A. Bocquet, O. Dumont, A. Jardel, L. Loufrani, P. Moreau, and D. Henrion
Flow-Induced Remodeling in Resistance Arteries From Obese Zucker Rats Is Associated With Endothelial Dysfunction
Hypertension, July 1, 2007; 50(1): 248 - 254.
[Abstract] [Full Text] [PDF]